Skip to content

Medication Assessment Through Real Time Information eXchange - Distributed Pharmaceutical Record System

Medication Assessment Through Real Time Information eXchange - Distributed Pharmaceutical Record System

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03076853
Acronym
MATRIX-DPRS
Enrollment
511
Registered
2017-03-10
Start date
2016-04-03
Completion date
2016-06-30
Last updated
2017-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients With Pharmaceutical Record

Brief summary

The aim of MATRIX-DPRS is to assess the clinical and organizational impacts of the use of the medication record, opened, filled and managed by pharmacists (from private office and hospital units) by hospital physicians in private and public healthcare establishments (volunteers), for three clinical contexts: anaesthesiology visit before surgery, medications abuse and emergency hospitalization, medications and elderly hospitalisations.

Detailed description

As part of the national 2012 PREPS call for proposals, a multidisciplinary research team was set up to design and develop methods in order to evaluate the efficiency and the performance of health data information systems. This team is composed of physicians and researchers in medical informatics, hospital information systems, biostatistics, process analysis and management in healthcare, ergonomics and usability. This study was aimed to evaluate the clinical and organizational impacts of the use of a new source of information brought by the pharmaceutical record, promoted by the national committee of pharmacists. This record is opened and filled for each patient by the pharmacist. It contains all the medication sold (prescribed by physician and OTC) by the patient. This record is used by almost all the private pharmacists. The French Health Ministry was looking for an evaluation of this new source of information by hospital physicians in order to be applied by any healthcare institution or organization wishing to evaluate the added value of its investments or recommendations (example: ARS (French Regional Health Agency), DGOS (French Directorate General of Health Services), etc.) in the information system.

Interventions

OTHEROpening of the Pharmaceutical Record

After a first prescription without the pharmaceutical record, the study investigator has to open the pharmaceutical record to obtain some additional data. After, he has to choose between maintain or modify his first prescription.

Sponsors

Centre Hospitalier Universitaire de Nice
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Concerning Anesthesia department: * Patients in pre-anesthesia consultation for scheduled intervention. Concerning Emergencies department: * Patients admitted for fainting fit Regarding patients hospitalized in geriatrics: * Patients admitted to geriatrics

Exclusion criteria

* Minors * Patients without administrative or judicial freedom if the authorization of the legal representative can not be collected.

Design outcomes

Primary

MeasureTime frameDescription
Modification of the medical prescription linked to the use of the pharmaceutical record3 monthsThe primary outcome measure is to evaluate the impact of the use of the pharmaceutical record on th medical prescription. The doctor writes a first medical prescription without using the pharmaceutical record and a second with the pharmaceutical record.The changes are analyzed.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026